Gbadegesin et al. identified a missense mutation in ANLN as a cause of focal segmental glomerulosclerosis (FSGS) and found the mutant ANLN displayed reduced binding to the scaffold protein CD2AP (Gbadegesin et al., 2014). This evidence concerns the gene CD2AP and focal segmental glomerulosclerosis.